MoodNCT03992586
Effect of Rose-colored Glass on Mood
A study testing Wearing pink glasses and Wearing clear glasses in people with Mood, run by Florida Center for Dermatology at 1 site in United States.
Trial summary
Decades of psychological research has highlighted the impact of visual perception on mood and happiness. The investigators hypothesized that literally seeing the world through rose colored glasses may have an effect on perception, mood, and happiness. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Mood
- What is being tested?
- Wearing pink glasses and Wearing clear glasses
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 38 participants
- Where
- 1 siteUnited States
- Study dates
- 30 Aug 2018to 30 Jun 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Subjects over 18 years of age.
Who cannot join
- Subjects who wear glasses on a regular basis.
Trial locations and contacts
1 site in 1 country.
United States1 site
St Vincent's Medical Center
Jacksonville, Florida, 32204
About this study
Official title: Effect of Rose-colored Glass on Mood: A Randomized Clinical Trial
Decades of psychological research has highlighted the impact of visual perception on mood and happiness. The investigators hypothesized that literally seeing the world through rose colored glasses may have an effect on perception, mood, and happiness. After cataract surgery, which classically increases the vividness of perceived colors, patients report significant satisfaction. The investigators therefore sought to explore whether using pink colored lenses leads to a measurable impact on outcomes.
Read the detailed description
A randomized controlled clinical trial design will be performed. Subjects will be randomized for either pink lenses (treatment group) or clear lenses (placebo group).
Subjects will be asked to wear the assigned glasses throughout the day during the course of the trial. Glasses will not be work while driving at night.
- Conditions
- Mood
- Being tested
- Wearing pink glasses, Wearing clear glasses
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Wearing pink glassesOther
Wearing pink-colored lenses
Wearing clear glassesOther
Wearing clear glasses
| Study group | Role | What they receive |
|---|---|---|
| Pink lenses | Experimental | Pink-colored lenses Receives: Other: Wearing pink glasses |
| Clear lenses | Placebo comparator | Clear lenses Receives: Other: Wearing clear glasses |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline in Anxiety Scores on the Visual Analogue Scale at 1 week
Scale range 0-100, higher values represent more anxiety
Measured: 1 week
Secondary outcomes (3)
Change from baseline in Mood Scores on the Visual Analogue Scale
Scale range 0-100, higher values represent more sadness
Measured: 1 week
Change from baseline in Happiness Scores on the Visual Analogue Scale
Scale range 0-100, higher values represent more happiness
Measured: 1 week
Change from baseline in the Center for Epidemiological Studies Depression Scale score
Scale range 0-60, higher values suggest more depressive symptoms
Measured: 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jun 2019
- Study start30 Aug 2018
- Primary completion30 Jun 2019
- Study completion30 Jun 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MoodStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Care provider, Investigator, Outcomes assessor
- Enrolment
- 38 participants (actual)
Sponsor and investigators
- Lead sponsor
- Florida Center for Dermatology
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jonathan Kantor, MD, Principal investigator, Florida Center for Dermatology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03992586
- Sponsor's protocol ID
- RCG101
- Status last verified
- Aug 2020
- First submitted
- 14 Aug 2018
- Last updated
- 25 Aug 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymized data are available to other researchers upon reasonable request.
Study at a glance
From the registry record, last updated by the sponsor on 25 Aug 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Rose-colored Glass on Mood: A Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT03992586
- Acronym / sponsor ID
- RCG101
- Conditions
- Mood
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 38 participants (actual)
- Lead sponsor
- Florida Center for DermatologyUniversity, hospital or other
- Study start
- 30 Aug 2018 (actual)
- Primary completion
- 30 Jun 2019 (actual)
- Study completion
- 30 Jun 2019 (actual)
- First posted
- 20 Jun 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Decades of psychological research has highlighted the impact of visual perception on mood and happiness. The investigators hypothesized that literally seeing the world through rose colored glasses may have an effect on perception, mood, and happiness. After cataract surgery, which classically increases the vividness of perceived colors, patients report significant satisfaction. The investigators therefore sought to explore whether using pink colored lenses leads to a measurable impact on outcomes.
Detailed description
A randomized controlled clinical trial design will be performed. Subjects will be randomized for either pink lenses (treatment group) or clear lenses (placebo group).
Subjects will be asked to wear the assigned glasses throughout the day during the course of the trial. Glasses will not be work while driving at night.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Pink lenses | Experimental | Other: Wearing pink glassesPink-colored lenses |
| Clear lenses | Placebo comparator | Other: Wearing clear glassesClear lenses |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Subjects over 18 years of age.
Key exclusion criteria (1 listed)
- Subjects who wear glasses on a regular basis.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Wearing pink glassesWearing pink-colored lenses | Other | Pink lenses |
| Wearing clear glassesWearing clear glasses | Other | Clear lenses |
Primary outcome
Change from baseline in Anxiety Scores on the Visual Analogue Scale at 1 week
Time frame: 1 week
Scale range 0-100, higher values represent more anxiety
3 secondary outcomes
Change from baseline in Mood Scores on the Visual Analogue Scale
Time frame: 1 week
Change from baseline in Happiness Scores on the Visual Analogue Scale
Time frame: 1 week
Change from baseline in the Center for Epidemiological Studies Depression Scale score
Time frame: 1 week
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Aug 2020.
- Individual participant dataSharing planned: Yes. Anonymized data are available to other researchers upon reasonable request.
Related trials for Mood
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
Recruiting
MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI
Schizophrenia Spectrum Disorders, Psychotic Affective Disorders
Recruiting
Affective Cognitive Training in Mood Disorders and High-risk Relatives
Major Depressive Disorder (MDD), Bipolar Disorder (BD)
Active, not recruiting
AI Mental Health Tool vs. Psychoeducation Control
Depressive Disorder, Depressive Symptoms
Recruiting
Restoring Emotional Needs With Exogenous Ketones for Women With Postpartum Depression
Postpartum Depression (PPD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jonathan Kantor, MD principal investigator
Florida Center for Dermatology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Wearing pink glasses and Wearing clear glasses in people with Mood, run by Florida Center for Dermatology at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline in Anxiety Scores on the Visual Analogue Scale at 1 week (time frame: 1 week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2020.